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Abstract 
The immune response induced by vaccination with Bacille Calmette-Guérin (BCG) is not fully 
understood, and the interpretation of the tuberculin skin test (TST) is still under debate. This thesis was 
based on questions raised while implementing protective measures for healthcare workers and others at 
risk of exposure to tuberculosis (TB) in Sweden, a country where the prevalence of TB is low. 
 
The present distribution of TST reactions in healthy young adults was analyzed, as well as the influence 
of various background factors on TST reactivity. Forty-two percent of BCG-vaccinated subjects had TST 
reactions ≥10 mm, while most unvaccinated subjects were non-reactive. BCG vaccination, geographic 
origin and age had decisive influence on TST reactivity. Most TST reactions in unvaccinated Swedish 
subjects were probably caused by cross-reactivity with non-tuberculous mycobacteria. Furthermore, the 
scar rate and TST reactivity after BCG vaccination was analyzed in children and adults. Vaccination of 
adults resulted in consistent scar formation, while scar prevalence in previously vaccinated children was 
low. There was a positive correlation between scar presence and TST reactivity in children as well as 
adults. Vaccinated subjects without a scar were TST positive more frequently than those non-vaccinated, 
indicating a systemic vaccine reaction in the absence of a local reaction. 
 
New opportunities to elucidate the above-mentioned issues have evolved from insights in the 
immunology of TB. A T-helper 1 (Th1) response is known to confer protection against TB. Markers of a 
Th1 response are e.g. production of interferon-gamma and lymphocyte proliferation after in vitro 
stimulation of peripheral blood mononuclear cells with tuberculin. These immune correlates were 
analyzed in relation to TST reactivity in previously BCG-vaccinated healthcare workers without known 
exposure to TB. Subjects with large positive TST reactions mounted a stronger Th1 response than TST 
negative subjects. Moreover, the corresponding in vitro analyses were performed before and after BCG 
vaccination of TST negative young adults. Both primary vaccination and revaccination caused a 
significant increase of the Th1 response, suggesting a protective effect against TB. 
 
In conclusion, a history of BCG vaccination and/or the presence of a BCG scar are strong predictors of 
TST reactivity in our setting. A BCG scar can be used as an indicator of a technically correct vaccination 
in adults but does not have the same implication after vaccination of children. IFN-γ has a decisive role in 
the Th1 response and in resistance against TB, but protective immunity against TB is more complex than 
the effects of T cell derived IFN-γ production only. The in vitro results should therefore be evaluated with 
caution. Yet, TST reactivity was associated with a protective immune response in vitro in BCG-
vaccinated adults without known TB exposure, and a corresponding response was induced by primary 
vaccination as well as revaccination of young adults. 
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